Contact us:
973-983-7429
support@4hcm.org

66 Ford Road - Suite 213B
Denville, NJ 07834


I need help with my HCM
Gordon Fox • February 8, 2022
Two new state-of-the-art reviews on HCM
Worldwide distribution of documented HCM cases.
Worldwide distribution of documented HCM cases.

An expert panel of HCM doctors published two state-of-the-art reviews in the Feb. 1, 2022 issue of Journal of the American College of Cardiology. The reviews are aimed at doctors who treat patients with HCM. But they include much information of interest to patients.

The reviews cover some ground different from the 2020 AHA/ACC consensus document on HCM diagnosis and treatment , and the authors reach some conclusions that are different from the AHA/ACC document. The members of the expert panel are Drs. Barry J. Maron, Miland Y. Desai, Rick A. Nishamura, Paolo Spirito, Harry Rakowski,  Jeffrey A. Towbin, Joseph A. Dearani, Ethan J. Rowin, Martin S. Maron, and Mark V. Sherrid. 

Some topics covered

Some of the topics covered include questions frequently raised by HCM patients, including

  • How to diagnose HCM;
  • How to use genetic testing for family screening;
  • What testing should be done at what intervals after diagnosis;
  • How often to screen children of those with HCM; and
  • Safe exercise recommendations.

Where to find the reviews

These reviews are open-access and freely available. You can use these links to read them:

HCMA Blog

March 24, 2025
Who should have genetic testing, and when?
A photo-realistic image of  heart, lit from behind, on a black background.
March 11, 2025
Health educator Sabrina Cuddy discusses common arrhythmias in HCM, like atrial flutter/fibrillation, ventricular tachycardia/fibrillation, left or right bundle branch block, PVC, PAC, and others. Some arrhythmias are harmless, while others are serious and need treatment.
Chart representing mavacamten trial results with total patients, and results in blue bar format.
By Gordon Fox March 10, 2025
Camzyos provided significant reduction of obstruction. Initially all patients were obstructed (that is, they had gradients of at least 30mmHg after valsalva maneuvers). After 3 months on Camzyos, about 57% were no longer obstructed. After 6 months, about 70% had no obstruction.
More Posts
Share by: